Эпилепсия и эпилептический статус у взрослых и детей
 Скачать 1.94 Mb.
|
|
Epilepsy Behav. 2021; 123:108269. 487. Gaspard N., Hirsch L. J., Sculier Cl., Loddenkemper T., Baalen A. van, Lancrenon J., Emmery M., Specchio N., Farias-Moeller R., Wong N., Nabbout R. New-Onset Refractory Status Epilepticus –NORSE and Febrile Infection-Related Epilepsy Syndrome –FIRES: state of the art and perspectives. Epilepsia. 2018;1–8. 488. Prasad M, Krishnan PR, Sequeira R, Al-Roomi K. Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev 2014; 9:CD003723. doi:10.1002/14651858.CD003723.pub3. 489. Chamberlain JM, Okada P, Holsti M, Mahajan P, Brown KM, Vance C, Gonzalez V, Lichenstein R, Stanley R, Brousseau DC, Grubenhoff J, et al. Lorazepam vs diazepam for pediatric status epilepticus: A randomized clinical trial. JAMA. 2014;311(16):1652–60 490. Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, Barsan W, Investigators N. Intramuscular versus intravenous therapy for prehospital status epilepticus. The New England journal of medicine. 2012;366(7):591–600 . 491. McIntyre J, Robertson S, Norris E, Appleton R, Whitehouse WP, Phillips B, Martland T, Berry K, Collier J, Smith S, Choonara I. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet. 2005;366(9481):205–10. 492. Talukdar B, Chakrabarty B. Efficacy of buccal midazolam compared to intravenous diazepam in controlling convulsions in children: a randomized controlled trial. Brain Dev. 2009;31(10):744–9. 243 493. Scott RC, Besag FM, Neville BG. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet. 1999;353(9153):623–6. 494. Mpimbaza A, Ndeezi G, Staedke S, Rosenthal PJ, Byarugaba J. Comparison of buccal midazolam with rectal diazepam in the treatment of prolonged seizures in ugandan children: a randomized clinical trial. Pediatrics. 2008;121(1):e58–64. 495. Trinka E, Höfler J, Zerbs A, Brigo F. Efficacy and safety of intravenous valproate for status epilepticus: a systematic review. CNS Drugs 2014;28:623-639 496. Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure. 2007;16(6):527–32 497. Malamiri RA, Ghaempanah M, Khosroshahi N, Nikkhah A, Bavarian B, Ashrafi MR. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial. Eur J Paediatr Neurol. 2012;16(5):536–41. 498. Mehta V, Singhi P, Singhi S. Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial. J Child Neurol. 2007;22(10):1191–7. 499. Hubert P., Parain D., Vallee L. Management of convulsive status epilepticus in infants and children. Rev Neurol (Paris). 2009 Apr;165(4):390-7. 500. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society. Epilepsy Curr 2016;16:48-61. 501. Trinka Eu., Ho¨fler J., Leitinger M., Brigo F. Pharmacotherapy for Status Epilepticus Drugs (2015) 75:1499–1521. 502. Misra UK, Kalita J, Maurya PK. Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study. J Neurol. 2012;259(4):645–8 503. Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. Evidence- based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society. Epilepsy Curr 2016;16:48-61. 504. Zelano J, Kumlien E. Levetiracetam as alternative stage two antiepileptic drug in status epilepticus: a systematic review. Seizure 2012;21:233-236 505. Kima D., Jae-Moon Kima, Yong Won Chob , Kw Ik Yangc Dong Wook Kimd , Soon-Tae Leee Young Joo Nof , Jong-Geun Seog Jung-Ick Byunh Kyung Wook Kangi Keun Tae Kimb Antiepileptic Drug Therapy for Status Epilepticus J Clin Neurol 2021;17(1):11-19. 244 506. Vossler D. G., Bainbridge J. L., Boggs J. G., Novotny E. J., Loddenkemper T., Faught E., Amengual-Gual M., Fischer S. N., Gloss D. S., Olson D. M., Towne A. R., Naritoku D., Welty. T. E. Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee. Epilepsy Currents 2020, Vol. 20(5) 245-264). 507. Santamarina E, González-Cuevas M, Toledo M, Jiménez M, Becerra JL, Quílez A, et al. Intravenous lacosamide (LCM) in status epilepticus (SE): weight-adjusted dose and efficacy. Epilepsy Behav 2018;84:93-98. 508. Ramsay RE, Sabharwal V, Khan F, Dave H, Kafai C, Shumate R, et al. Safety & pK of IV loading dose of lacosamide in the ICU. Epilepsy Behav 2015;49:340-342. 509. Shorvon S, Baulac M, Cross H, Trinka E, Walker M; Task Force on Status Epilepticus of the ILAE Commission for European Affairs. The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia 2008;49:1277-1285. 510. Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 2011;134:2802-2818. 511. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002;43:146-153. 512. Rossetti AO, Milligan TA, Vulliémoz S, Michaelides C, Bertschi M, Lee JW. A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care 2011;14:4-10. 513. Gomes D, Pimentel J, Bentes C, Aguiar de Sousa D, Antunes AP, Alvarez A, et al. Consensus protocol for the treatment of super-refractory status epilepticus. Acta Med Port 2018;31:598-605. 514.Fung LW, Yam KM; Yau M. LY. Ketamine use for super-refractory status epilepticus in children. Hong Kong Med J 2020 Dec;26(6):549–50. 515. Rosati A, L'Erario M, Ilvento L, Cecchi C, Pisano T, Mirabile L, et al. Efficacy and safety of ketamine in refractory status epilepticus in children. Neurology 2012;79:2355-2358. 516. Kramer U, Chi C-S, Lin K-L, et al. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia. 2011;52:1956–65. 517. Hirsch LJ, Gaspard N, van Baalen A, et al. Proposed consensus definitions for new- onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia. 2018. https://doi.org/10.1111/epi.14016 245 518. Khawaja AM, DeWolfe JL, Miller DW, Szaflarski JP. New-onset refractory status epilepticus (NORSE)–the potential role for immunotherapy. Epilepsy Behav. 2015;47:17–23. 519. Zeiler F.A., Matuszczak M., Teitebaum J., Kazina C.J., Gillman L.M.. Plasmopheresis for refractory status epilepticus Part I: a scoping systematic review of adult literature. Seizures,2016 43:14- 22. 520. Zeiler F.A., Matuszczak M., Teitebaum J., Kazina C.J., Gillman L.M. Plasmopheresis for refractory status epilepticus Part II: a scoping systematic review of pediatric literature. Seizures, 2016 43:61-68.. 521. Zeiler F A, Zeiler K J , Teitelbaum J , Gillman L M , West M. VNS for refractory status/Epilepsy Res 2015 May;112:100-13. 522. Dibue-Adjei M, Brigo Fr., Yamamoto T., Vonck Kr., Trinka Eu.. Vagus nerve stimulation in refractory and super-refractory status epilepticus e A systematic review/ Brain Stimulation 12 (2019) 1101e1110. 523. O'Connor SE , Ream MA, Richardson C, Mikati MA, Trescher WH, Byler DL et al. The ketogenic diet for the treatment of pediatric status epilepticus Pediatr Neurol. 2014 Jan;50(1):101-3. 524. Lai-wah Eva Fung The ketogenic diet for the treatment of pediatric status epilepticus Pediatr Neurol. 2014 Aug;51(2):e7. doi: 10.1016/j.pediatrneurol.2014.03.016. 525. Barkovich A.J., Guerrini R., Kuznetsk RI. et al. A developmental and genetic classification for malformations of cortical development: update 2012 // Brain. – 2012.- V.135.- P. 1348 – 1369. 526. Pearl P.L. Inherited metabolic epilepsies: the top 10 diagnoses you cannot afford to miss. // In: Inherited metabolic epilepsies / Eds. P.L. Pearl. – 2013. – DesmosMedical, N.Y. – P.1-13. 527. Hauser W.A. Epidemiology of epilepsy in children. // In: Eds.: J.M. Pellock, D.R. Nordli, Sankar R., Wheless J.W. / Pellock᾽s Pediatric Epilepsy. Diagnosis and their Therapy, 4 th edition – DemosMedical, USA. – 2017. – P. 177 – 205. 528. Hsu WW et al. Systematic review and meta-analysis of the efficacy and safety of perampanel in the treatment of partial-onset epilepsy. CNS Drugs. 2013 Oct; 27(10):817-27. doi: 10.1007/s40263-013-0091-9. Erratum in: CNS Drugs. 2013 Dec;27(12):1143. PMID: 23918722; PMCID: PMC3784051.• 529. Steinhoff BJ et al. Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies. Epilepsia. 2013 Aug;54(8):1481-9. doi: 10.1111/epi.12212. Epub 2013 May 10. PMID: 23663001. 246 530. O'Callaghan FJ, Edwards SW, Alber FD, Hancock E, Johnson AL, Kennedy CR, Likeman M, Lux AL, Mackay M, Mallick AA, Newton RW, Nolan M, Pressler R, Rating D, Schmitt B, Verity CM, Osborne JP; participating investigators. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial. Lancet Neurol. 2017 Jan;16(1):33-42. doi: 10.1016/S1474-4422(16)30294-0. Epub 2016 Nov 10. PMID: 27838190. 531. Chellamuthu P, Sharma S, Jain P, Kaushik JS, Seth A, Aneja S. High dose (4 mg/kg/day) versus usual dose (2 mg/kg/day) oral prednisolone for treatment of infantile spasms: an open-label, randomized controlled trial. Epilepsy Res. 2014 Oct;108(8):1378-84. doi: 10.1016/j.eplepsyres.2014.06.019. Epub 2014 Jul 5. PMID: 25048310. 532. Gaspard N, Hirsch LJ, Sculier C, Loddenkemper T, van Baalen A, Lancrenon J, Emmery M, Specchio N, Farias-Moeller R, Wong N, Nabbout R. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives. Epilepsia. 2018 Apr;59(4):745-752. doi: 10.1111/epi.14022. Epub 2018 Feb 24. PMID: 29476535. 533. van Engelen B. G. M. et al. Immunoglobulin treatment in epilepsy, a review of the literature //Epilepsy research. – 1994. – Т. 19. – №. 3. – С. 181-190. 534. Бембеева Р.Ц., Заваденко Н.Н. Внутривенные иммуноглобулины в терапии аутоиммунных заболеваний нервной системы у детей. Журнал неврологии и психиатрии им. С.С. Корсакова. 2015;115(8):83-93. 535.Sourbron J. et al. Ketogenic diet for the treatment of pediatric epilepsy: review and meta-analysis //Child's Nervous System. – 2020. – Т. 36. – №. 6. – С. 1099-1109. 536. Zi-yu Zhao, Hong-ying Wang, Bin Wen, Zhi-bo Yang, Kang Feng, Jing-chun Fan. A Comparison of Midazolam, Lorazepam, and Diazepam for the Treatment of Status Epilepticus in Children: A Network Meta-analysis. Journal of Child Neurology. 2017, 1-15; 537. Prasad M, Krishnan PR, Sequeira R, Al-Roomi K. Anticonvulsant therapy for status epilepticus. Cochrane Database of Systematic Reviews 2014, Issue 9. Art. No.: CD003723. DOI: 10.1002/14651858.CD003723.pub3). 538. D. G. Vossler, J. L. Bainbridge, J. G. Boggs, E. J. Novotny, T. Loddenkemper, E. Faught, M. Amengual-Gual, S. N. Fischer , D. S. Gloss, D. M. Olson, A. R. Towne, D. Naritoku, T. E. Welty. Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee. Epilepsy Currents 2020, Vol. 20(5) 245-264. 539. D.G. Vossler, J.L. Bainbridge, J.G. Boggs, E.J. Novotny, T.Loddenkemper, E. Faught, M. Amengual-Gual, S.N. Fischer, D.S. Gloss, D.M. Olson, A.R. Towne, D. Naritoku, T. 247 E. Welty. Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee. Epilepsy Currents 2020, Vol. 20(5) 245- 264; 540. Daeyoung Kima , Jae-Moon Kima Yong Won Chob , Kwang Ik Yangc Dong Wook Kimd , Soon-Tae Leee Young Joo Nof , Jong-Geun Seog Jung-Ick Byunh Kyung Wook Kangi Keun Tae Kimb. Antiepileptic Drug Therapy for Status Epilepticus. J Clin Neurol 2021;17(1):11-19. 541. Cetin Okuyaz, Kürşad Aydin, Kivilcim Gücüyener, Ayşe Serdaroğlu. Treatment of electrical status epilepticus during slow-wave sleep with high-dose corticosteroid. Pediatr Neurol. 2005 Jan;32(1):64-7; B. 542. van den Munckhof, Al. Arzimanoglou, E. Perucca, H. C. van Teeseling, F. S. S. Leijten, K. P. J. Braun, Fl. E. Jansen. Corticosteroids versus clobazam in epileptic encephalopathy with ESES: a European multicentre randomised controlled clinical trial (RESCUE ESES*) Trials 2020 Nov 23;21(1):957. 543.Клинические рекомендации «Алгоритмы специализированной медицинской помощи больным с сахарным диабетом»/ под ред. И.И. Дедова, М.В. Шестаковой, А.Ю Майорова. 10-й выпуск. 2021; 24(S1): С 70-71. 544. Клинические рекомендации по сердечно-легочной реанимации у детей. Российский национальный Совет по реанимации. Объединение детских анестезиологов реаниматологов. 2014г) 545. Shpak AA, Guekht AB, Druzhkova TA, Rider FK, Gulyaeva NV. Brain-derived neurotrophic factor in blood serum and lacrimal fluid of patients with focal epilepsy. Epilepsy Res. 2021 Oct; 176:106707. doi: 10.1016/j.eplepsyres.2021.106707. Epub 2021 Jun 29. PMID: 34225232. 546. Международная классификация болезней (10 пересмотр). Классификация психических и поведенческих расстройств. Санкт-Петербург, 1994; 300 с. 547. Базилевич С.Н., Прокудин М.Ю., Аверьянов Д.А., Дыскин Д.Е. Эпилептический статус: реальность 2021 // Известия Российской Военно-медицинской академии. - 2021. - Т. 40. - №4. - C. 59-68. doi: 10.17816/rmmar83623 548. M. Ngampoopun, P. Suwanpakdee, N. Jaisupa, Ch. Nabangchang. Effectiveness and Adverse Effect of Intravenous Lacosamide in Nonconvulsive Status Epilepticus and Acute Repetitive Seizures in Children. Neurol Res Int. 2018 Jun 10;2018:8432859. doi: 10.1155/2018/8432859. eCollection 2018. 248 549. Arkilo D., Gustafson M., Ritter F. J. Clinical experience of intravenous lacosamide in infants and young children. European Journal of Paediatric Neurology. 2016;20(2):212–217. doi: 10.1016/j.ejpn.2015.12.013 550. Northam R.S., Hernandez A.W., Litzinger M.J., Minecan D.N., Glauser T.A., Mangat S., Zheng C., Souppart C., Sturm Y. Oxcarbazepine in infants and young children with partial seizures. Oxcarbazepine in infants and young children with partial seizures. Pediatr Neurol. 2005 Nov;33(5):337- 44. doi: 10.1016/j.pediatrneurol.2005.05.011. PMID: 16243221. 551. Elterman R., Glauser T.A., Wyllie E., et al, and the Topiramate YP Study Group: A double blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Neurology 1999; 52:1338–1344. 552. de la Rosa J. S. O. et al. Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review //Seizure. – 2018. – Т. 56. – С. 34-40. 553. Yorns Jr W. R. et al. Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy //Journal of child neurology. – 2014. – Т. 29. – №. 1. – С. 23-27. 554. Verhelst H. et al. Steroids in intractable childhood epilepsy: clinical experience and review of the literature //Seizure. – 2005. – Т. 14. – №. 6. – С. 412-421. 555. Kurian M., Korff C. M. Steroids in pediatric epilepsy: infantile spasms and beyond //Epileptologie. – 2011. – Т. 28. – №. 1. – С. 15-20. Приложение А1. Состав рабочей группы по разработке и пересмотру клинических рекомендаций Айвазян Сергей Оганесович, к.м.н, доцент кафедры неврологии детского возраста ГБОУ ДПО РМАПО Минздрава РФ, ведущий научный сотрудник Научно- практического центра медицинской помощи детям ДЗМ. Акжигитов Ренат Гайясович, к.м.н., заместитель директора ГБУЗ «Научно- практический психоневрологический центр имени З.П. Соловьева» Департамента здравоохранения города Москвы. Алферова Вера Вадимовна, д.м.н., главный научный сотрудник кафедры неврологии, нейрохирургии и медицинской генетики ФГАОУ ВО «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Министерства здравоохранения Российской Федерации, член президиума Всероссийского общества неврологов. Бадалян Оганес Левонович, д.м.н., профессор кафедры неврологии, нейрохирургии и медицинской генетики лечебного факультета ФГАОУ ВО «Российский 249 национальный исследовательский медицинский университет имени Н.И. Пирогова» Министерства здравоохранения Российской Федерации Базилевич Сергей Николаевич, к.м.н., доцент кафедры и клиники нервных болезней им. М.И. Аствацатурова ФГБВОУ ВО «Военно-медицинская академия им. С. М. Кирова» Министерства обороны Российской Федерации. Батышева Татьяна Тимофеевна, д.м.н., профессор, Главный внештатный детский специалист невролог, Директор ГБУЗ «Научно-практический центр детской психоневрологии ДЗМ». Белкин Андрей Августович, д.м.н., профессор кафедры физической и реабилитационной медицины федерального государственного бюджетного образовательного учреждения высшего образования "Уральский государственный медицинский университет" Министерства здравоохранения Российской Федерации, директор ООО «Клинический институт мозга», профессор, главный внештатный специалист УрФО РФ по медицинской реабилитации. Белоусова Елена Дмитриевна, д.м.н., профессор ФГАОУ ВО «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Министерства здравоохранения Российской Федерации, заведующая отделом психоневрологии и эпилептологии ОСП Научно-исследовательский клинический институт педиатрии им. Ю.Е. Вельтищева. |